Stephanie Siegmund, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sex Cord-Gonadal Stromal Tumors | 5 | 2023 | 118 | 2.610 |
Why?
|
Testicular Neoplasms | 6 | 2023 | 799 | 2.390 |
Why?
|
Adenoma, Oxyphilic | 3 | 2024 | 148 | 1.170 |
Why?
|
Sertoli Cell Tumor | 2 | 2023 | 36 | 1.090 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2023 | 218 | 0.780 |
Why?
|
Granular Cell Tumor | 1 | 2021 | 48 | 0.770 |
Why?
|
Granulosa Cell Tumor | 1 | 2021 | 77 | 0.740 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 491 | 0.570 |
Why?
|
Ovarian Neoplasms | 3 | 2024 | 4877 | 0.520 |
Why?
|
Kidney Neoplasms | 4 | 2024 | 4246 | 0.480 |
Why?
|
Mitochondrial Diseases | 1 | 2017 | 344 | 0.450 |
Why?
|
Carcinoma, Renal Cell | 3 | 2023 | 3161 | 0.450 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 869 | 0.400 |
Why?
|
Sirolimus | 1 | 2017 | 1533 | 0.360 |
Why?
|
Germ-Line Mutation | 3 | 2023 | 1858 | 0.350 |
Why?
|
Immunohistochemistry | 3 | 2024 | 11070 | 0.240 |
Why?
|
Epidermodysplasia Verruciformis | 1 | 2024 | 22 | 0.230 |
Why?
|
Seminal Vesicles | 1 | 2024 | 103 | 0.230 |
Why?
|
Carney Complex | 1 | 2023 | 15 | 0.220 |
Why?
|
Genes, APC | 1 | 2023 | 144 | 0.210 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2023 | 181 | 0.210 |
Why?
|
Mutation | 8 | 2024 | 30044 | 0.210 |
Why?
|
Colorectal Neoplasms | 1 | 2022 | 6901 | 0.200 |
Why?
|
Sweat Gland Neoplasms | 1 | 2024 | 116 | 0.200 |
Why?
|
Mitochondria | 4 | 2020 | 3624 | 0.200 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2024 | 194 | 0.190 |
Why?
|
Germ Cells | 2 | 2022 | 634 | 0.190 |
Why?
|
Sarcoma, Kaposi | 1 | 2024 | 374 | 0.180 |
Why?
|
Cytoplasmic Vesicles | 1 | 2020 | 73 | 0.170 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2024 | 487 | 0.170 |
Why?
|
Electron Microscope Tomography | 1 | 2019 | 17 | 0.170 |
Why?
|
beta Catenin | 1 | 2023 | 1040 | 0.150 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 1742 | 0.150 |
Why?
|
BRCA2 Protein | 1 | 2022 | 804 | 0.140 |
Why?
|
Thymidine Kinase | 1 | 2017 | 286 | 0.140 |
Why?
|
Chromatography, Affinity | 1 | 2018 | 532 | 0.140 |
Why?
|
DNA Copy Number Variations | 2 | 2022 | 2020 | 0.140 |
Why?
|
Ribosomes | 1 | 2020 | 501 | 0.140 |
Why?
|
Electron Transport Complex I | 1 | 2017 | 153 | 0.140 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2022 | 2509 | 0.130 |
Why?
|
Gene Knock-In Techniques | 1 | 2017 | 421 | 0.130 |
Why?
|
Diagnosis, Differential | 4 | 2024 | 12972 | 0.130 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2023 | 781 | 0.130 |
Why?
|
BRCA1 Protein | 1 | 2022 | 1155 | 0.130 |
Why?
|
Oxidative Phosphorylation | 1 | 2017 | 497 | 0.130 |
Why?
|
Breast Neoplasms | 1 | 2022 | 21009 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2023 | 2060 | 0.110 |
Why?
|
Endoplasmic Reticulum | 1 | 2020 | 1133 | 0.110 |
Why?
|
Cytomegalovirus | 1 | 2018 | 756 | 0.110 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2023 | 3638 | 0.110 |
Why?
|
Manduca | 1 | 2012 | 13 | 0.110 |
Why?
|
Benzimidazoles | 1 | 2018 | 858 | 0.100 |
Why?
|
Sarcoma | 1 | 2023 | 1793 | 0.100 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2022 | 2052 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1610 | 0.100 |
Why?
|
Receptor, erbB-2 | 1 | 2022 | 2556 | 0.100 |
Why?
|
Male | 12 | 2024 | 360621 | 0.100 |
Why?
|
Syndrome | 1 | 2017 | 3268 | 0.090 |
Why?
|
DNA, Viral | 1 | 2018 | 2201 | 0.090 |
Why?
|
Thyroid Neoplasms | 1 | 2024 | 2332 | 0.090 |
Why?
|
Cryoelectron Microscopy | 3 | 2020 | 650 | 0.090 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 2210 | 0.090 |
Why?
|
Plant Proteins | 1 | 2012 | 369 | 0.090 |
Why?
|
Autophagy | 1 | 2017 | 1321 | 0.080 |
Why?
|
Humans | 17 | 2024 | 761326 | 0.080 |
Why?
|
Adenocarcinoma | 2 | 2024 | 6332 | 0.080 |
Why?
|
Saccharomyces cerevisiae | 1 | 2018 | 2687 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2018 | 3057 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10764 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 5363 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2024 | 5820 | 0.060 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2024 | 59 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5303 | 0.060 |
Why?
|
Cystadenoma, Mucinous | 1 | 2024 | 62 | 0.060 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2024 | 191 | 0.060 |
Why?
|
Chromosome Duplication | 1 | 2023 | 75 | 0.060 |
Why?
|
Adnexal Diseases | 1 | 2024 | 105 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2024 | 256 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2024 | 214 | 0.050 |
Why?
|
S100 Proteins | 1 | 2022 | 218 | 0.050 |
Why?
|
Sequence Analysis | 1 | 2022 | 240 | 0.050 |
Why?
|
Female | 6 | 2024 | 392485 | 0.050 |
Why?
|
Loss of Heterozygosity | 1 | 2023 | 662 | 0.050 |
Why?
|
Nucleotides | 1 | 2023 | 454 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11116 | 0.040 |
Why?
|
Chromosomes | 1 | 2022 | 577 | 0.040 |
Why?
|
Hydrocarbons, Halogenated | 1 | 2018 | 20 | 0.040 |
Why?
|
Golgi Apparatus | 1 | 2020 | 405 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13333 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18234 | 0.040 |
Why?
|
Adult | 5 | 2024 | 221122 | 0.040 |
Why?
|
Electron Transport Complex IV | 1 | 2018 | 190 | 0.040 |
Why?
|
Papillomaviridae | 1 | 2024 | 1119 | 0.040 |
Why?
|
Histidine | 1 | 2018 | 308 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2023 | 1771 | 0.040 |
Why?
|
Databases as Topic | 1 | 2019 | 473 | 0.040 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2018 | 158 | 0.030 |
Why?
|
Automation | 1 | 2019 | 587 | 0.030 |
Why?
|
Guinea Pigs | 1 | 2018 | 1317 | 0.030 |
Why?
|
Animals | 5 | 2020 | 168388 | 0.030 |
Why?
|
Biological Transport | 1 | 2020 | 2090 | 0.030 |
Why?
|
Organ Specificity | 1 | 2020 | 1967 | 0.030 |
Why?
|
Magnetics | 1 | 2018 | 599 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23427 | 0.030 |
Why?
|
Mice | 2 | 2020 | 81474 | 0.030 |
Why?
|
Genome, Viral | 1 | 2018 | 665 | 0.030 |
Why?
|
Rats | 2 | 2020 | 23729 | 0.030 |
Why?
|
Molecular Imaging | 1 | 2020 | 815 | 0.030 |
Why?
|
Flowers | 1 | 2012 | 31 | 0.030 |
Why?
|
Plants, Genetically Modified | 1 | 2012 | 115 | 0.030 |
Why?
|
Fusarium | 1 | 2012 | 51 | 0.030 |
Why?
|
Oxylipins | 1 | 2012 | 53 | 0.030 |
Why?
|
Cyclopentanes | 1 | 2012 | 87 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2020 | 1403 | 0.030 |
Why?
|
Plant Roots | 1 | 2012 | 117 | 0.030 |
Why?
|
Mitochondrial Proteins | 1 | 2018 | 979 | 0.020 |
Why?
|
Plant Leaves | 1 | 2012 | 150 | 0.020 |
Why?
|
Gene Expression Regulation, Plant | 1 | 2012 | 211 | 0.020 |
Why?
|
Plant Diseases | 1 | 2012 | 178 | 0.020 |
Why?
|
Cytomegalovirus Infections | 1 | 2018 | 831 | 0.020 |
Why?
|
Acetates | 1 | 2012 | 321 | 0.020 |
Why?
|
Biopsy | 1 | 2023 | 6768 | 0.020 |
Why?
|
Contrast Media | 1 | 2024 | 5310 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 80575 | 0.020 |
Why?
|
Virus Replication | 1 | 2018 | 2435 | 0.020 |
Why?
|
Middle Aged | 4 | 2024 | 220774 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2024 | 5297 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14665 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2018 | 1841 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6525 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4139 | 0.020 |
Why?
|
Aged | 3 | 2024 | 169179 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2012 | 4175 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2012 | 2062 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3577 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4740 | 0.020 |
Why?
|
Gene Silencing | 1 | 2012 | 1509 | 0.020 |
Why?
|
Cell Line | 1 | 2019 | 15599 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20092 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2012 | 3734 | 0.010 |
Why?
|
Cell Membrane | 1 | 2012 | 3687 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 18962 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8997 | 0.010 |
Why?
|
Base Sequence | 1 | 2012 | 12449 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5778 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2024 | 20555 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17640 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 58946 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 14025 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54405 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 59196 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36430 | 0.010 |
Why?
|